CRP and bipolar disorder: Lurasidone in both children and adults treated for bipolar depression is of particular interest because of the drug’s good tolerability and weight neutrality and the unusual findings that the drug has the largest effect size in patients who have evidence of inflammation (high level of CRP) at baseline.